A Clinical-Stage Biotech Company that Bridges Science and Culture
With research and development hubs in the U.S., Shanghai, and Berlin, our deep scientific expertise and innate problem-solving enable Anji to bring medicines to patients around the world – quickly and safely.
We Get Science Done
At Anji, “getting it done” is our north star. We prioritize high-value, late-stage therapies with human validation that they will work. It’s an approach that brings higher clinical success rates, lower development costs, and long-term value for our partners. No red tape, no hype; just a steadfast focus on results that outperforms traditional asset-centric business models.
The only rules we follow:
- Pick Good Targets – prioritize human validation, genetics, and pharmacology
- Unlock Value – via capital-efficient clinical development and definitive proof-of-concept
- Design Optionality into Clinical Development – we develop therapies with intent to commercialize, but optionality to partner so we may ready the next wave of targets
Focused on Results
We are united by a pioneering spirit and a passion for helping patients improve their quality of life. Taking a “best idea wins” approach, we leverage our hub-and-spoke model to drive short- term success while building a foundation for long-term growth.
Where History Meets Modern Science
Our name was inspired by the Anji Bridge (Zhaozhou Bridge), one of the oldest stone-arch bridges in the world. Anji translates to “safe crossing,” a term that captures our free exchange of innovative science and ideas. It also means “to aid those in need,” aptly reflecting our own mission of improving the lives of patients everywhere.
With its ingenious construction, the Anji Bridge has weathered wars, floods, and earthquakes for over 1,400 years. It stands as a model of strength, efficiency, and long-term sustainability, the very qualities that define our work.